Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 541 - Bayesian Design in Clinical Trial and Some Challenging Issues
Type: Topic Contributed
Date/Time: Thursday, August 11, 2022 : 10:30 AM to 12:20 PM
Sponsor: Section on Bayesian Statistical Science
Abstract #322614
Title: Bayesian Design in Clinical Trial and Some Challenging Issues
Author(s): Fei Wang*
Companies: Boehringer Ingelheim
Keywords: Bayesian monitoring; Bayesian sample size determination; clinical trial; adaptive design

Statistical methods in clinical trial monitoring have been developed in many applications. With the recent surge of adaptive and complex innovative design programs, fixed design is rarely the case anymore. Pre-planned interim analyses and monitoring are routinely done in practice. The goal is to develop safe and effective products and serve patients as fast as possible by using all the knowledge gained in research and development. Futility due to safety concerns and suboptimal therapeutic effects should be carefully examined as well. We will look at some decision metrics for these interim analyses, in relation to Bayesian sample size determination and simulation-based design. Bayesian design is flexible and should be transparent. The proposed sampling approach and decision criterion attempt to connect with clinical trial design and implementation.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program